GILEAD SCIENCES, INC. — Director's Dealing 2015

Jan 12, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-01-08

Reporting Person: Carter Paul Rutherford (EVP Commercial Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-01-08	Common Stock	M	717	$40.56	Acquired	35025	Direct
2015-01-08	Common Stock	M	283	$26.99	Acquired	35308	Direct
2015-01-08	Common Stock	S	1000	$100.8805	Disposed	34308	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-01-08	Non-Qualified Stock Option (right to buy)	$26.99	M	283	Disposed	2018-07-30	Common Stock (283)	Direct
2015-01-08	Non-Qualified Stock Option (right to buy)	$40.56	M	717	Disposed	2023-02-01	Common Stock (717)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

F3: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F4: Sale prices reported for the transactions reported here range from $100.88 to $100.89. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.